This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Delirium in patients with Parkinson's disease

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

Seek specialist advice when managing delirium in Parkinson's disease

  • a major problem in the management of patients with Parkinson's disease can be drug-induced neuropsychiatric problems such as visual hallucinations and confusion

  • drugs such as olanzapine have fewer extrapyrimadal side effects that other antipsychotic drugs and therefore are less likely to worsen parkisonism when used; however advice has stressed the concerns of using newer antipsychotics such as olanzapine and risperidone in the elderly (2)

  • other causes of an acute confusional state should be considered

Reference:

  1. Update (1998); 57(2): 122-30.
  2. Summary - Guidance for the management of behavioural and psychiatric symptoms in dementia and the treatment of psychosis in people with history of stroke/TIA. Working group for the Faculty of Old Age Psychiatry RCPsych, RCGP, BGS, and Alzheimer's Society, following CSM restriction on risperidone and olanzapine. April 2004

Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.